Coherus Oncology, Inc. (CHRS) Earnings
NASDAQ·Healthcare·Biotechnology
$1.07
+4.95%
Mkt Cap $165.32M
EPS — Estimate vs Actual
Mkt Cap
$165.32M
P/E
1.27
Fwd P/E
—
P/S
3.16
Rev TTM
—
EPS TTM
-$1.28
NASDAQ·Healthcare·Biotechnology
$1.07
+4.95%
Mkt Cap $165.32M
Mkt Cap
$165.32M
P/E
1.27
Fwd P/E
—
P/S
3.16
Rev TTM
—
EPS TTM
-$1.28